Consequences of chronic pancreatitis and exocrine pancreatic insufficiency, or When leaves fall from trees
PDF (Українська)

Keywords

chronic pancreatitis, exocrine pancreatic insufficiency, complications, cardiovascular pathology, decreased bone mineral density, quality of life, enzyme replacement therapy

How to Cite

Gubergrits, N. B., Byelyayeva, N. V., & Mozhyna, T. L. (2023). Consequences of chronic pancreatitis and exocrine pancreatic insufficiency, or When leaves fall from trees. Herald of Pancreatic Club, 58(1), 20-31. https://doi.org/10.33149/vkp.2023.01.03

Abstract views: 47
PDF Downloads: 30

Abstract

Aim. To analyze current literature data on the complications of chronic pancreatitis (CP) with exocrine pancreatic insufficiency (EPI).

Main statements. According to statistical evidence, the presence of CP is associated with an increased risk of death, while the concomitant EPI significantly increases the risk of death. EPI is a big independent risk factor for death in patients with CP, which emphasizes the need for adequate correction of EPI in order to reduce mortality in this group.

EPI is associated not only with an increase in mortality in CP patients but also with the development of various trophological defects. It has been stated that CP course is accompanied by a decrease in the level of albumin, malabsorption of fat-soluble vitamins (A, E, and D), carotenoids (beta-carotene, lycopene, cryptotaxin, and zeaxanthin), and the development of osteopenia and osteoporosis. CP course is linked to anxiety, depression, tumor pathology (pancreatic ductal adenocarcinoma, esophageal cancer, and stomach cancer), damage to the cardiovascular system, an increase in cardiovascular risk, and a high chance of myocardial infarction, stroke, and pancreatitis-induced thrombosis of the splenic vein. Modern enzyme replacement therapy makes it possible to compensate for some of the consequences of chronic EPI, reduce numerous signs of malnutrition, normalize the body mass index, and improve the quality of life of CP patients with EPI.

https://doi.org/10.33149/vkp.2023.01.03
PDF (Українська)

References

1. Alkhayyat M., Abou Saleh M., Coronado W., Abureesh M., Al-Otoom O., Qapaja T., Mansoor E., Simons-Linares C. R., Stevens T, Chahal P. Increasing prevalence of anxiety and depression disorders after diagnosis of chronic pancreatitis: a 5-year population-based study. Pancreas. 2021. Vol. 50, No 2. P. 153–159.
2. Bang U. C., Benfield T., Hyldstrup L., Bendtsen F., Jensen J. E. Mortality, cancer, and comorbidities associated with chronic pancreatitis: a Danish nationwide matched-cohort study. Gastroenterology. 2014. Vol. 146, No 4. P. 989–994.
3. Bideyeva T. V., Andreyev D. N., Kucheryavy Yu. A., Maev I. V. Dynamics of vitamin D level in patients with chronic pancreatitis on the background of enzyme replacement therapy. Meditsinskiy sovet = Medical Council. 2019. No 3. P. 156–160. (In Russ.)
4. Bundred J., Thakkar R. G., Pandanaboyana S. Systematic review of sarcopenia in chronic pancreatitis: prevalence, impact on surgical outcomes, and survival. Expert Rev. Gastroenterol. Hepatol. 2022. Vol. 16, No 7. P. 665–672.
5. Butler J. R., Eckert G. J., Zyromski N. J., Leonardi M. J., Lillemoe K. D., Howard T. J. Natural history of pancreatitis-induced splenic vein thrombosis: a systematic review and meta-analysis of its incidence and rate of gastrointestinal bleeding. HPB (Oxford). 2011. Vol. 13, No 12. P. 839–845.
6. Cai F., Hu C., Chen C. J., Han Y. P., Lin Z. Q., Deng L. H., Xia Q. Vitamin D and pancreatitis: a narrative review of current evidence. Nutrients. 2022. Vol. 14, No 10. P. 2113.
7. Dams O. C., Vijver M. A. T., van Veldhuisen C. L., Verdonk R. C., Besselink M. G., van Veldhuisen D. J. Heart failure and pancreas exocrine insufficiency: pathophysiological mechanisms and clinical point of view. J. Clin. Med. 2022. Vol. 11, No 14. P. 4128.
8. de la Iglesia D., Vallejo-Senra N., López-López A., Iglesias‐Garcia J., Lariño‐Noia J., Nieto‐García L., Domínguez‐Muñoz J. E. Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: A prospective, longitudinal cohort study. J. Gastroenterol. Hepatol. 2019. Vol. 34, No 1. P. 277–283.
9. de la Iglesia-Garcia D., Vallejo-Senra N., Iglesias-Garcia J., López-López A., Nieto L., Domínguez-Muñoz J. E. Increased risk of mortality associated with pancreatic exocrine insufficiency in patients with chronic pancreatitis. J. Clin. Gastroenterol. 2018. Vol. 52, No 8. P. e63–e72.
10. Duggan S. N., Purcell C., Kilbane M., O’keane M., McKenna M., Gaffney P., Ridgway P. F., Boran G., Conlon K. C. An association between abnormal bone turnover, systemic inflammation, and osteoporosis in patients with chronic pancreatitis: a case-matched study. Am. J. Gastroenterol. 2015. Vol. 110, No 2. P. 336–345.
11. Duggan S. N., Smyth N. D., O’Sullivan M., Feehan S., Ridgway P. F., Conlon K. C. The prevalence of malnutrition and fat-soluble vitamin deficiencies in chronic pancreatitis. Nutr. Clin. Pract. 2014. Vol. 29, No 3. P. 348–354.
12. Erchinger F., Engjom T., Dimcevski G., Drewes A. M., Olesen S. S., Vujasinovic M., Löhr J. M., Nøjgaard C., Novovic S., Laukkarinen J., Parhiala M. Exocrine pancreas insufficiency in chronic pancreatitis — Risk factors and associations with complications. A multicentre study of 1869 patients. Pancreatology. 2022. Vol. 22, No 3. P. 374–380.
13. Erchinger F., Tjora E., Nordaas I. K., Dimcevski G., Olesen S. S., Jensen N., Dahl E. E., Borch A., Nøjgaard C., Novovic S., Barauskas G. Pancreatic enzyme treatment in chronic pancreatitis: Quality of management and adherence to guidelines-A cross-sectional observational study. United European Gastroenterol. J. 2022. Vol. 10, No 8. P. 844–853.
14. Fasullo M., Omer E., Kaspar M. Sarcopenia in chronic pancreatitis — prevalence, diagnosis, mechanisms and potential therapies. Curr. Gastroenterol. Rep. 2022. Vol. 24, No 4. P. 53–63.
15. Gandhi S., de la Fuente J., Murad M. H., Majumder S. Chronic pancreatitis is a risk factor for pancreatic cancer, and incidence increases with duration of disease: a systematic review and meta-analysis. Clin. Transl. Gastroenterol. 2022. Vol. 13, No 3. P. e00463.
16. Gopi S., Qamar S., Singh N., Agarwal S., Yegurla J., Rana A., Gunjan D., Saraya A. Malnutrition by GLIM criteria in chronic pancreatitis: Prevalence, predictors, and its impact on quality of life. Pancreatology. 2022. Vol. 22, No 3. P. 367–373.
17. Gubergrits N., Malecka-Panas E., Lehman G. A., Vasileva G., Shen Y., Sander‐Struckmeier S., Caras S., Whitcomb D. C. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery. Aliment. Pharmacol. Ther. 2011. Vol. 33, No 10. P. 1152–1161.
18. Gupta N., Singh S., Vargas L., Moore T. E., Shostrom V. K., Boerner B. P. Prevalence of low bone density and comorbid hypogonadism in patients with chronic pancreatitis. Pancreas. 2019. Vol. 48, No 3. P. 387–395.
19. Han M., Tran T. P.T., Oh J. K. Chronic pancreatitis and cancer risk in a matched cohort study using national claims data in South Korea. Sci. Rep. 2022. Vol. 12, No 1. P. 5545.
20. Jøker-Jensen H., Mathiasen A. S., Køhler M., Rasmussen H. H., Drewes A. M., Olesen S. S. Micronutrient deficits in patients with chronic pancreatitis: prevalence, risk factors and pitfalls. Eur. J. Gastroenterol. Hepatol. 2020. Vol. 32, No 10. P. 1328–1334.
21. Kempeneers M. A., Ahmed Ali U., Issa Y., van Goor H., Drenth J. P., van Dullemen H. M., van Hooft J. E., Poen A. C., Van Veldhuisen S. L., Besselink M. G., van Santvoort H. C. Natural course and treatment of pancreatic exocrine insufficiency in a nationwide cohort of chronic pancreatitis. Pancreas. 2020. Vol. 49, No 2. P. 242–248.
22. Khan M., Rutkowski W., Vujasinovic M., Löhr J. M. Adherence to European guidelines for treatment and management of pancreatic exocrine insufficiency in chronic pancreatitis patients. J. Clin. Med. 2021. Vol. 10, No 12. P. 2737.
23. Kuan L. L., Dennison A. R., Garcea G. Prevalence and impact of sarcopenia in chronic pancreatitis: a review of the literature. World J. Surg. 2021. Vol. 45, No 2. P. 590–597.
24. Lindkvist B. Diagnosis and treatment of pancreatic exocrine insufficiency. World J. Gastroenterol. 2013. Vol. 19, No 42. P. 7258–7266.
25. Löhr J. M., Dominguez-Munoz E., Rosendahl J., Besselink M., Mayerle J., Lerch M. M., Haas S., Akisik F., Kartalis N., Iglesias-Garcia J., Keller J. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol. J. 2017. Vol. 5, No 2. P. 153–199.
26. Machicado J. D., Papachristou G. I. Pancreatogenic diabetes, acute pancreatitis management, and pancreatic tuberculosis: Appraising the present and setting goals for the future. United European Gastroenterol. J. 2020. Vol. 8, No 4. P. 365–368.
27. Maev I. V., Andreev D. N., Kucheryavyy Y. A., Levchenko A. I. The prevalence of sarcopenia in patients with chronic pancreatitis: a meta-analysis. Ter. Arkh. 2020. Vol. 92, No 12. P. 43–47.
28. Maev I. V., Kucheryavyy Y. A., Gubergrits N. B., Bonnacker I., Shelest E. A., Janssen-van Solingen G. P., Domínguez-Muñoz J. E. Differences in in vitro properties of pancreatin preparations for pancreatic exocrine insufficiency as marketed in Russia and CIS. Drugs R&D. 2020. Vol. 20, No 4. P. 369–376.
29. Makar M., Vodusek Z., Xia W., Greenberg P., Abdelsayed G. G. Rising prevalence of anxiety and depression in chronic pancreatitis: a nationwide analysis. Pancreas. 2022. Vol. 51, No 4. P. 325–329.
30. Martínez-Moneo E., Stigliano S., Hedström A., Kaczka A., Malvik M., Waldthaler A., Maisonneuve P., Simon P., Capurso G. Deficiency of fat-soluble vitamins in chronic pancreatitis: A systematic review and meta-analysis. Pancreatology. 2016. Vol. 16, No 6. P. 988–994.
31. Min M., Patel B., Han S., Bocelli L., Kheder J., Vaze A., Wassef W. Exocrine pancreatic insufficiency and malnutrition in chronic pancreatitis: identification, treatment, and consequences. Pancreas. 2018. Vol. 47, No 8. P. 1015–1018.
32. Munigala S., Agarwal B., Gelrud A., Conwell D. L. Chronic pancreatitis and fracture: a retrospective, population-based veterans administration study. Pancreas. 2016. Vol. 45, No 3. P. 355–361.
33. Nikolic S., Dugic A., Steiner C., Tsolakis A. V., Löfman I. M., Löhr J. M., Vujasinovic M. Chronic pancreatitis and the heart disease: Still terra incognita? World J. Gastroenterol. 2019. Vol. 25, No 44. P. 6561–6570.
34. Olesen S. S., Büyükuslu A., Køhler M., Rasmussen H. H., Drewes A. M. Sarcopenia associates with increased hospitalization rates and reduced survival in patients with chronic pancreatitis. Pancreatology. 2019. Vol. 19, No 2. P. 245–251.
35. Olesen S. S., Nøjgaard C., Poulsen J. L., Haas S. L., Vujasinovic M., Löhr M., Lindkvist B., Bexander L., Gulbinas A., Kalaitzakis E., Ebrahim M. Chronic pancreatitis is characterized by distinct complication clusters that associate with etiological risk factors. Am. J. Gastroenterol. 2019. Vol. 114, No 4. P. 656–664.
36. Ramesh H., Reddy N., Bhatia S., Rajkumar J. S., Bapaye A., Kini D., Kalla M., Thorat V. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40 000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis. Pancreatology. 2013. Vol. 13, No 2. P. 133–139.
37. Shintakuya R., Uemura K., Murakami Y., Kondo N., Nakagawa N., Urabe K., Okano K., Awai K., Higaki T., Sueda T. Sarcopenia is closely associated with pancreatic exocrine insufficiency in patients with pancreatic disease. Pancreatology. 2017. Vol. 17, No 1. P. 70–75.
38. Sikkens E. C., Cahen D. L., Koch A. D., Braat H., Poley J. W., Kuipers E. J., Bruno M. J. The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. Pancreatology. 2013. Vol. 13, No 3. P. 238–242.
39. Stigliano S., Waldthaler A., Martinez-Moneo E., Lionetto L., Robinson S., Malvik M., Hedstrom A., Kaczka A., Scholdei M., Haas S., Simmaco M. Vitamins D and K as factors associated with osteopathy in chronic pancreatitis: a prospective multicentre study (P-BONE Study). Clin. Transl. Gastroenterol. 2018. Vol. 9, No 10. P. 197.
40. Vujasinovic M., Dugic A., Nouri A., Brismar T. B., Baldaque-Silva F., Asplund E., Rutkowski W., Ghorbani P., Sparrelid E., Hagström H., Löhr J. M. Vascular complications in patients with chronic pancreatitis. J. Clin. Med. 2021. Vol. 10, No 16. P. 3720.
41. Vujasinovic M., Nezirevic Dobrijevic L., Asplund E., Rutkowski W., Dugic A., Kahn M., Dahlman I., Sääf M., Hagström H., Löhr J. M. Low bone mineral density and risk for osteoporotic fractures in patients with chronic pancreatitis. Nutrients. 2021. Vol. 13, No 7. P. 2386.
42. Yadav D., Askew R. L., Palermo T., Li L., Andersen D. K., Chen M., Fisher W. E., Fogel E. L., Forsmark C. E., Hart P. A., Othman M. O. Association of chronic pancreatitis pain features with physical, mental and social health. Clin. Gastroenterol. Hepatol. 2022. S1542-3565(22)00924-7.
43. Zhang J., Fan H., Gross M., Liu N., Carlson H., Wood A., Hoffman K., Petrosino J., Pankratz N., Thyagarajan B., Fisher W. Progressive reduction in circulating levels of carotenoids and other micronutrients in patients with chronic pancreatitis. Pancreatology. 2022. Vol. 22, No 8. Р. 1126–1133.
License